As AI-fueled innovations continue to transform medical technology and redefine therapeutic possibilities, organizations that anticipate the shift and prepare for the promise of precision medicine to come to fruition will be best set to join the next generation. In this two-part series, Guidehouse experts detail 4 key elements life sciences organizations must consider before drug therapies can take full advantage of precision medicine to meet the unique needs of patients.

1. Real-world evidence is coming to the fore
2. The role of the data scientist is evolving
3. The role of the physician is changing
4. Precision medicine diagnostics will become its own discipline

Read the full byline in Cell&Gene.